Pariveda Drugs & Pharmaceuticals Private Limited

Pariveda Drugs & Pharmaceuticals Private Limited - pharma in Chandrapur, Maharashtra, India. FY 2026 financials & compliance.
CIN U51101MH2013PTC247055 Incorporated 16 August 2013 ROC Nagpur HQ Chandrapur, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹17.34 Lakh
▲ 41% YoY
Net profit · FY 2025
₹21,252
Net margin 1.2%
EBITDA · FY 2025
₹26,451
EBITDA margin 1.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered

About Pariveda Drugs & Pharmaceuticals Private Limited

Data last updated:

Pariveda Drugs & Pharmaceuticals Private Limited is a private limited company based in Chandrapur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 August 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U51101MH2013PTC247055. Its GSTIN is 36AACCI1991B1ZT (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rohith Pariveda and Venkateswara Rao Nagineni.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No: 90/Lti Res 1 – Phase 2160/Chandrapur – 11 (U) S/Dn Ayadhya Nagar Tukum Chandrapu, R, Maharashtra, India – 442401.

As per the financials filed for FY 2025, the company reported a revenue of ₹17.34 Lakh, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹21,252 (net margin 1.2%) and EBITDA of ₹26,451 (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51101MH2013PTC247055
Registration Number 247055
Incorporation Date 16 August 2013
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Pariveda Drugs & Pharmaceuticals Private Limited's registered office is in Chandrapur, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    No: 90/Lti Res 1 – Phase 2160/Chandrapur – 11 (U) S/Dn Ayadhya Nagar Tukum Chandrapu, R, Maharashtra, India – 442401
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Pariveda Drugs & Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Pariveda Drugs & Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Pariveda Drugs & Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Pariveda Drugs & Pharmaceuticals Private Limited, buy the company report.

Financials of Pariveda Drugs & Pharmaceuticals Private Limited

FY 2025 filings available

Pariveda Drugs & Pharmaceuticals Private Limited reported revenue of ₹17.34 Lakh (up 41% YoY) for FY 2025.

Revenue · FY 2025
₹17.34 Lakh ▲ 41%
Net profit · FY 2025
₹21,252 margin 1.2%
EBITDA · FY 2025
₹26,451 margin 1.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 41%
3 years · compounded
▼ 5%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 58%
3 years · compounded
▼ 29%
5 years · compounded
▼ 26%

Revenue rose 41% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹26,451
Profit Before Tax
Tax Expense
Net Profit (PAT)₹21,252
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.5%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pariveda Drugs & Pharmaceuticals Private Limited, buy the company report.

Board of directors of Pariveda Drugs & Pharmaceuticals Private Limited

Pariveda Drugs & Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rohith ParivedaDirector20 Dec 20178 Years 10 MonthsCurrent
Venkateswara Rao NagineniDirector03 Oct 201610 Years 1 MonthsCurrent
Venkateshwar Rao ParivedaDirector16 Aug 201313 Years 2 MonthsCurrent

Auditor

Pariveda Drugs & Pharmaceuticals Private Limited is audited by UJJINENI & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
UJJINENI & COFY 2019010157S

Shareholding

The shareholding of Pariveda Drugs & Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pariveda Drugs & Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pariveda Drugs & Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Pariveda Drugs & Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AACCI1991B1ZTTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Pariveda Drugs & Pharmaceuticals Private Limited, buy the company report.

Recent activity

Pariveda Drugs & Pharmaceuticals Private Limited has 5 board changes on record since 2013: 3 appointments and 2 cessations. The latest: Vasundhara Pariveda ceased to be Managing Director on 15 Apr 2019.

AGM
Pariveda Drugs & Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pariveda Drugs & Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Ceased
Vasundhara Pariveda ceased to be Managing Director.
Appointed
Rohith Pariveda was appointed as Director.
Ceased
Venkateswara Rao Nagineni ceased to be Director.
Appointed
Venkateswara Rao Nagineni was appointed as Director.
Appointed
Venkateshwar Rao Pariveda was appointed as Director.
Incorporation
16 Aug 2013
Pariveda Drugs & Pharmaceuticals Private Limited was registered on 16 Aug 2013 with Roc Nagpur & aged 13 years 2 months as per MCA records.

Frequently asked questions

Pariveda Drugs & Pharmaceuticals is an active private limited company based in Chandrapur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 August 2013 (13+ years old) and is registered under CIN U51101MH2013PTC247055.

Pariveda Drugs & Pharmaceuticals has 3 current directors:

The latest financial statements of Pariveda Drugs & Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Pariveda Drugs & Pharmaceuticals is 36AACCI1991B1ZT, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Pariveda Drugs & Pharmaceuticals is U51101MH2013PTC247055. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pariveda Drugs & Pharmaceuticals was incorporated on 16 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Nagpur.

Vasundhara Pariveda ceased to be Managing Director on 15 Apr 2019. Rohith Pariveda was appointed as Director on 20 Dec 2017. Venkateswara Rao Nagineni ceased to be Director on 20 Dec 2017. Pariveda Drugs & Pharmaceuticals has 5 board changes on record in total.

The registered office of Pariveda Drugs & Pharmaceuticals is at No: 90Lti Res 1 – Phase 2160Chandrapur – 11 U SDn Ayadhya Nagar Tukum Chandrapu, R, Maharashtra, India – 442401.

Pariveda Drugs & Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Pariveda Drugs & Pharmaceuticals is compliant as of 28 August 2026. The company is actively filing with the Registrar of Companies.